Genetic testing finds breast cancer risks that standard screening models miss
View as a Web Page
News Medical
 
  Breast Cancer Breast Cancer logo  
  The latest breast cancer news from News Medical  
 Could GLP-1 drugs help prevent breast cancer? New study points to a possible linkCould GLP-1 drugs help prevent breast cancer? New study points to a possible link
 
A large retrospective cohort study of 111,646 overweight or obese women found that GLP-1 agonist exposure was associated with lower breast cancer incidence. After propensity-score matching, GLP-1 exposure was linked to nearly 30% lower odds of breast cancer, but the authors stress that randomized trials are needed before these drugs can be considered for prevention.
 
 
 Genetic testing finds breast cancer risks that standard screening models missGenetic testing finds breast cancer risks that standard screening models miss
 
Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed by clinical risk models, even when polygenic risk scores were added. In the WISDOM Study analysis, fewer than 1% of high-penetrance variant carriers would have received the same high-risk screening recommendation using clinical plus polygenic risk alone.
 
   Current-free wireless fields selectively alter immune and cancer cell migrationCurrent-free wireless fields selectively alter immune and cancer cell migration
 
Traditional electrotaxis assays place electrodes directly into the cell culture medium, which inevitably drives current through the sample.
 
   How common spices may improve gut, brain, and metabolic healthHow common spices may improve gut, brain, and metabolic health
 
The health effects of spices are explored, revealing their potential to influence blood sugar, inflammation, and brain function through various mechanisms.
 
   Strength training and cardio combo work best togetherStrength training and cardio combo work best together
 
Research shows that combining resistance training with aerobic exercise significantly reduces mortality risk, emphasizing the importance of physical activity.
 
 Millions live with undiagnosed heart rhythm disorders – World Heart Rhythm Week 2026 calls for urgent action
 
Millions live with undiagnosed heart rhythm disorders – World Heart Rhythm Week 2026 calls for urgent actionMillions of people worldwide are living with undiagnosed heart rhythm disorders that can lead to stroke, heart failure or sudden cardiac death – often with little or no warning.
 
 
 Three-drug strategy forces pancreatic tumors into lasting regression
 
Three-drug strategy forces pancreatic tumors into lasting regressionA triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression by blocking KRAS/RAS, EGFR/HER2, and STAT3 signaling. The approach prevented treatment resistance across mouse and human tumor-derived models, but remains preclinical and requires more clinically suitable drug combinations before human testing.
 
 
 Brain-targeted estrogen reduces breast cancer treatment side effects
 
Brain-targeted estrogen reduces breast cancer treatment side effectsMost breast cancers are worsened by estrogens. To combat the recurrence of these cancers, clinicians treat patients with inhibitors for estrogen production, like letrozole. But many patients do not adhere to this treatment due to negative side effects.
 
 
 New AI tool cuts breast cancer biopsy wait times
 
New AI tool cuts breast cancer biopsy wait timesWomen with abnormal mammograms often have to wait for weeks to find out whether they have breast cancer.
 
 
 Blocking sugar modification could boost breast cancer immunotherapy success
 
Blocking sugar modification could boost breast cancer immunotherapy successImmunotherapies such as so-called checkpoint inhibitors activate the body's own immune system to fight cancer cells and have revolutionized the treatment of many types of tumor.
 
 
 Study identifies key protein driving colon cancer drug resistance
 
Study identifies key protein driving colon cancer drug resistanceOne of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment that has improved outcomes for countless patients.
 
 
 How endotoxin-free proteins reduce hidden risks in cancer and immunology research
 
Discover how endotoxin-free proteins help minimize hidden experimental risks in cancer and immunology research.
 
 
 DNA study links BRCA genes to aggressive early-onset breast cancer in black women
 
Black women experience disproportionately elevated risks of developing and dying from early-onset breast cancer. New research published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, reveals the genes that are most likely to be mutated to contribute to these increased risks.
 
 
 Obesity alters tumor environment promoting invasive breast cancer growth
 
Obesity may change how early-stage breast cancer becomes invasive, according to a study by University of Oklahoma researchers published in The American Journal of Pathology.
 
 
 New X-ray system produces high-resolution images with less radiation
 
X-rays allow professionals to diagnose injuries or ailments and peer inside suitcases at the airport, along with a variety of other applications.
 
 
 Review highlights TIGIT as a promising second-generation immunotherapy target
 
Malignant tumors remain a major threat to human health, with conventional therapies and first-generation immune checkpoint inhibitors (ICIs) facing limitations like drug resistance and low response rates.
 
 
 Study reveals how breast cancer cells hide in the bone marrow
 
Treating breast cancer remains a major medical challenge worldwide. This is largely due to the ability of breast cancer cells to remain hidden for years before triggering a relapse, which can occur even decades after successful treatment of the primary tumor.
 
 
 Gene test helps many breast cancer patients avoid chemotherapy
 
Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without increasing the risk of the cancer returning, a large international clinical trial led by UCL has found.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026